Azitra (AZTR) Amortizatization of Intangibles (2022 - 2026)
Azitra (AZTR) posted Amortizatization of Intangibles of $78961.0 for Q1 2026, up 1.11% on a QoQ basis from $78094.0 in Q4 2025, and down 5.28% year-over-year from $83360.0 in Q1 2025.
Azitra (AZTR) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Azitra's Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $78961.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles fell 5.28% year-over-year to $78961.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $310676.0 (down 2.28% YoY) and the FY2025 annual result came in at $315075.0, down 0.62% from the prior year.
- Amortizatization of Intangibles was $78961.0 for Q1 2026 at Azitra, up from $78094.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $274197.0 in Q4 2022 and bottomed at -$135026.0 in Q3 2022.
- A 5-year average of $76410.0 and a median of $78094.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- Peak annual rise in Amortizatization of Intangibles reached 159.19% in 2023, while the deepest fall reached 72.2% in 2023.
- Azitra's Amortizatization of Intangibles stood at $274197.0 in 2022, then tumbled by 72.2% to $76238.0 in 2023, then advanced by 8.23% to $82510.0 in 2024, then dropped by 5.35% to $78094.0 in 2025, then rose by 1.11% to $78961.0 in 2026.
- Business Quant data shows AZTR's Amortizatization of Intangibles at $78961.0 in Q1 2026, $78094.0 in Q4 2025, and $77235.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.11 Bn | 1,785.05 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.57 Bn | 468.78 Bn | 1.35 Bn | - |
| 4 | Vertex Pharmaceuticals | 123.78 Bn | 116.54 Bn | 2.59 Bn | - |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.98 Bn | 3.31 Bn | - |
| 6 | Belite Bio | 62.12 Bn | 62.12 Bn | - | - |
| 7 | Argenx Se | 54.64 Bn | 49.45 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.05 Bn | 35.05 Bn | 959.66 Mn | - |
| 9 | Revolution Medicines | 36.28 Bn | 36.28 Bn | - | 3.22 Mn |
| 10 | Azitra | 2.03 Mn | 2.03 Mn | - | 78,961.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78,961.00 |
| Mar 31, 2026 | 78,961.00 |
| Dec 31, 2025 | 78,094.00 |
| Dec 31, 2025 | 78,094.00 |
| Sep 30, 2025 | 77,235.00 |
| Sep 30, 2025 | 77,235.00 |
| Jun 30, 2025 | 76,386.00 |
| Jun 30, 2025 | 76,386.00 |
| Mar 31, 2025 | 83,360.00 |
| Mar 31, 2025 | 83,360.00 |
| Dec 31, 2024 | 82,510.00 |
| Dec 31, 2024 | 82,510.00 |
| Sep 30, 2024 | 70,636.00 |
| Sep 30, 2024 | 70,636.00 |
| Jun 30, 2024 | 81,434.00 |
| Jun 30, 2024 | 81,434.00 |
| Mar 31, 2024 | 82,467.00 |
| Mar 31, 2024 | 82,467.00 |
| Dec 31, 2023 | 76,238.00 |
| Dec 31, 2023 | 76,238.00 |